|
1 Indications And Usage Welchol Is A Bile Acid Sequestrant Indicated As An Adjunct To Diet And Exercise To: Reduce Elevated Low-Density Lipoprotein Cholesterol (Ldl-C) In Adults With Primary Hyperlipidemia ( 1.1 ). Reduce Ldl-C Levels In Boys And Postmenarchal Girls, 10 To 17 Years Of Age, With Heterozygous Familial Hypercholesterolemia (Hefh) ( 1.1 ). Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus ( 1.2 ). Limitations Of Use ( 1.3 ): Do Not Use For Treatment Of Type 1 Diabetes Or For Diabetic Ketoacidosis. The Effect On Cardiovascular Morbidity And Mortality Has Not Been Determined. Not Studied In Type 2 Diabetes With A Dipeptidyl Peptidase 4 Inhibitor Not Studied In Fredrickson Type I, Iii, Iv, And V Dyslipidemias Not Studied In Children Less Than 10 Years Of Age Or In Premenarchal Girls 1.1 Primary Hyperlipidemia Welchol Is Indicated As An Adjunct To Diet And Exercise To Reduce Elevated Low-Density Lipoprotein Cholesterol (Ldl-C) In Adults With Primary Hyperlipidemia. Welchol Is Indicated To Reduce Ldl-C Levels In Boys And Postmenarchal Girls, 10 To 17 Years Of Age, With Heterozygous Familial Hypercholesterolemia (Hefh) Who Are Unable To Reach Ldl-C Target Levels Despite An Adequate Trial Of Dietary Therapy And Lifestyle Modification. 1.2 Type 2 Diabetes Mellitus Welchol Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus . 1.3 Limitations Of Use Welchol Should Not Be Used For The Treatment Of Type 1 Diabetes Or For The Treatment Of Diabetic Ketoacidosis. The Effect Of Welchol On Cardiovascular Morbidity And Mortality Has Not Been Determined. Welchol Has Not Been Studied In Type 2 Diabetes In Combination With A Dipeptidyl Peptidase 4 Inhibitor. Welchol Has Not Been Studied In Fredrickson Type I, Iii, Iv, And V Dyslipidemias. Welchol Has Not Been Studied In Children Younger Than 10 Years Of Age Or In Premenarchal Girls.
|